Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility
- Genetics in Medicine
- (2014)
- 16,
- 225–227
- doi:10.1038/gim.2013.158
- Received
- Accepted
- Published online
In the current issue of Genetics in Medicine, Phillips et al.1 report a thorough systematic review of published cost-utility analyses (CUAs) of clinical molecular genetic tests, or personalized medicine tests as the authors refer to them. By analyzing the Tufts Cost-Effectiveness Analysis Registry, the authors identified 59 CUAs published from…
No hay comentarios:
Publicar un comentario